Stephen Liggett is the Regulatory Services Manager for Venn Life Sciences.
He is driven to translate scientific innovation into healthcare products, delivering patients benefits. Previously, he acted as a consultant to a wide variety of innovative companies operating in the Pharma, Biotech and Medical Device Industries. Stephen worked in the NHS, industry and academia having taught Regulatory Affairs internationally.
He has been recognised by industry through the TOPRA Futures award in 2016 for his work on cell therapies and other cutting-edge regulatory projects. The MHRA also have a case study featuring his involvement in developing a Microneedle Array Patch and he has several publications on translating research into healthcare products.
In his role at Venn Life Sciences, Stephen uses his regulatory and technology transfer expertise to support research groups in academia and industry. Stephen holds an MPharm and PhD from Queens University Belfast.
